3IDP
B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor
3IDP の概要
| エントリーDOI | 10.2210/pdb3idp/pdb |
| 分子名称 | B-Raf proto-oncogene serine/threonine-protein kinase, N~1~-(4-chlorophenyl)-6-methyl-N~5~-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine (3 entities in total) |
| 機能のキーワード | oncogene, atp-binding, dfg-out, transferase, cardiomyopathy, disease mutation, kinase, metal-binding, nucleotide-binding, phorbol-ester binding, phosphoprotein, proto-oncogene, serine/threonine-protein kinase, zinc-finger |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Nucleus (By similarity): P15056 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 69985.57 |
| 構造登録者 | |
| 主引用文献 | Smith, A.L.,Demorin, F.F.,Paras, N.A.,Huang, Q.,Petkus, J.K.,Doherty, E.M.,Nixey, T.,Kim, J.L.,Whittington, D.A.,Epstein, L.F.,Lee, M.R.,Rose, M.J.,Babij, C.,Fernando, M.,Hess, K.,Le, Q.,Beltran, P.,Carnahan, J. Selective inhibitors of the mutant B-raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline. J.Med.Chem., 52:6189-6192, 2009 Cited by PubMed Abstract: The discovery and optimization of a novel series of aminoisoquinolines as potent, selective, and efficacious inhibitors of the mutant B-Raf pathway is presented. The N-linked pyridylpyrimidine benzamide 2 was identified as a potent, modestly selective inhibitor of the B-Raf enzyme. Replacement of the benzamide with an aminoisoquinoline core significantly improved kinase selectivity and imparted favorable pharmacokinetic properties, leading to the identification of 1 as a potent antitumor agent in xenograft models. PubMed: 19764794DOI: 10.1021/jm901081g 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.7 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






